Ligand profile

ZINC1216218

Virtual-screening candidate from ZINC.

Bound to: VK055_0424 — NMT1/THI5 like family protein

Via homolog UniProt Q187U0 Formula C₂₀H₂₇N₄O₂S⁺
Tanimoto 0.58
Mol. weight 387.53 Da
Permeability High
PAINS Clean

Identifiers

Database identifiers and provenance.

Ligand ID
ZINC1216218
UniProt (similar protein)
Q187U0
Tanimoto
0.581
Target protein
VK055_0424

Structure

2D representation rendered from SMILES.

Physicochemical properties

Computed with RDKit from SMILES.

Molecular weight 387.53 Da
LogP (Crippen) 2.74
H-bond donors 1
H-bond acceptors 6
TPSA 81.98 Ų
Rotatable bonds 6
Aromatic rings 2 / 4
Heavy atoms 27
Fraction sp³ C 0.60
Formula C₂₀H₂₇N₄O₂S⁺

Drug-likeness

Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.

Permeability proxy High

Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.

  • TPSA ≤ 90 Ų 82.0
  • −1 ≤ LogP ≤ 5 2.74
Lipinski's Rule of Five Pass 0 violations
  • MW ≤ 500 Da 387.5
  • LogP ≤ 5 2.74
  • H-bond donors ≤ 5 1
  • H-bond acceptors ≤ 10 6
Veber's rules Pass
  • Rotatable bonds ≤ 10 6
  • TPSA ≤ 140 Ų 82.0
PAINS Clean

No PAINS structural alerts detected.

Chemical representations

Canonical representations for cheminformatics workflows.

SMILES 
Cc1ncc(C[n+]2csc(CCOC(=O)C34CCC(CC3)C4)c2C)c(N)n1
InChI 
InChI=1S/C20H27N4O2S/c1-13-17(5-8-26-19(25)20-6-3-15(9-20)4-7-20)27-12-24(13)11-16-10-22-14(2)23-18(16)21/h10,12,15H,3-9,11H2,1-2H3,(H2,21,22,23)/q+1
InChIKey 
SNQYTSHJQRKIIW-UHFFFAOYSA-N

Provenance

Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.

Method
LigQ nearest_k
Query
VIB
Homolog
Q187U0

External resources

Open this ligand in third-party databases and cheminformatics tools.

Other ligands for this protein

Quick navigation to other ligands bound to VK055_0424.

PDB 1

Ligands co-crystallized with this protein (structural evidence).

Ligand PDB entry

ZINC 28

Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).

Compound Similarity (Tanimoto)